According to the new market research report "Gastrointestinal Stent Market with COVID-19 Impact by Product (biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents), Material (self-expanding metal stents and plastic stents), Application, End User - Forecast to 2026", published by MarketsandMarkets™, the global market is expected to reach USD 600 million by 2026 from USD 457 million in 2021, at a CAGR of 5.6% during the forecast period of 2021 to 2026.
Browse in-depth TOC on "Gastrointestinal Stent Market"
197 – Tables
50 – Figures
223 – Pages
Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=167758126
The growth of this market is mainly attributed to the rising prevalence of GI cancers and other digestive diseases, and changing lifestyles, increasing healthcare expenditure on gastrointestinal procedures, and increasing preference for minimally invasive surgeries. However, complications associated with GI stenting procedures and High cost of the procedure and limited reimbursement in developing countries are factors expected to restrain the market growth. Moreover, the development of biodegradable and drug eluting stents and booming healthcare sector in emerging markets is expected to provide lucrative opportunities for the growth of the market in the coming years.
Increasing prevalence of bile duct cancer and chronic liver disease to drive the demand for biliary stents.
Based on product, the gastrointestinal stent market is segmented into biliary stents, duodenal stents, colonic stents, pancreatic stents, and esophageal stents. The biliary stents segment accounted for the largest share of 44.3% in 2020. The Esophageal Stents segment is estimated to grow at the highest CAGR during the forecast period. The increasing prevalence of bile duct cancer and chronic liver disease is one of the prominent factors responsible for the growth of the biliary stents segment. Moreover, The increasing incidence of biliary diseases and the growth in the number of surgical procedures for the treatment of biliary diseases are the other major factors that are expected to support the growth of this market segment during the forecast period.
The self-expanding metal stent segment will dominate the gastrointestinal stent market, by material
Based on material, the GI Stent Market is segmented into self-expanding metal stents and plastic stents. Self-expanding metal stents are further sub-segmented into nitinol, stainless steel, and other metal stents. Factors such as the increased demand for Self-expanding metal stents due to advantages offered by these stents such as ease of insertion, a lower possibility of dislodgment or migration, longer patency. Metal stents are usually made of stainless steel, nitinol, cobalt-chromium, and platinum-chromium with or without coating. Self-expanding metal stents are used for the treatment of benign gastrointestinal leaks and perforations. These stents act as a support to keep the gastrointestinal tract open and provide easy unobstructed drainage of food and water.
Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=167758126
The Gastrointestinal Cancers segment to register the fastest growth in the gastrointestinal stent market, by application
Based on application, the GI Stent Market is segmented into biliary diseases, irritable bowel syndrome, and gastrointestinal cancers. The gastrointestinal cancers segment is further categorized into colorectal cancer, stomach cancer, esophageal cancer, and pancreatic cancer. The biliary diseases segment accounted for the largest share in 2020. The gastrointestinal cancers segment is projected to have the highest CAGR during the forecast period. The growth of this segment is attributed to the increased prevalence and incidences of gastrointestinal cancers. For instance, according to a report by the American Cancer Society, Colorectal Cancer Facts & Figures 2020-2022, in 2020, there were an estimated 104,610 new cases of colon cancer and 43,340 cases of rectal cancer diagnosed in the US
The hospitals and clinics segment accounted for the largest market share in 2020
Based on end users, the gastrointestinal stent market is segmented into hospitals and clinics and ambulatory surgical centers. The hospitals and clinics segment accounted for the largest share of in 2020. The large share of this segment can be attributed to the large number of endoscopic retrograde cholangio-pancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) procedures performed in hospitals for different disease indications, favorable reimbursement scenarios, and increased government initiatives to provide quality treatment for gastrointestinal diseases.
North America was the largest regional market for Gastrointestinal Stent market in 2020
The Gastrointestinal Stents market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latina America, and the Middle East and Africa. In 2020, North America accounted for the largest share. The large share of North America in the global market is attributed to the rising geriatric population, high incidence of gastrointestinal diseases, favourable reimbursement scenario, and presence of key market players. Some of the major players in this market are Boston Scientific Corporation (US), C.R. Bard (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cook Medical (US), Cantel Medical (US), and Hobbs Medical (US).
Some of the prominent players in this Gastrointestinal Stent Market are Boston Scientific Corporation (US), Cook Group (US), Medtronic plc. (Ireland), ELLA-CS, s.r.o. (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED Corporation (US), Cantel Medical (US), Olympus Corporation (Japan), Taewoong Medical (South Korea), Micro-Tech(Nanjing) Co., Ltd. (China), Endo-Flex GmbH (Germany), MI-Tech (South Korea), Hobbs Medical Inc. (US), QualiMed (Germany), UK Medical (UK), CITEC (China), Medorah Meditek Pvt. Ltd. (India), BCM Corporation (South Korea), and Leufen Medical GmbH (Germany).
Browse Related Reports:
Endoscopic Retrograde Cholangiopancreatography/ERCP Market by Product (Upper GI endoscopes, Stent, Balloons, Catheters, Baskets), Procedure (Biliary Sphincterotomy & Stenting, Pancreatic Sphincterotomy), End User (Hospitals) - Global Forecast to 2026
The report covers detailed Gastrointestinal / GI Stent Market analysis by Product, Application, Region, Major Player, Market Size, Share, Trends, Growth and Forecast 2018-2025.
The Global Gastrointestinal / GI Stent Market is projected to grow at a healthy growth rate from 2018 to 2025 according to new research.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies.
It also presents insights into various restraints that pose threat and highlights opportunities that will help the market pick pace in the forthcoming years.
The report compiles exhaustive information obtained via proven research methodologies and from trusted sources from within the industries.
It also includes expert opinions to provide readers a clearer perspective regarding the global market.
According to the new market research report, "Clinical Trial Supplies Market by Services (Manufacturing, Packaging, Logistics, Distribution), Phases (I to IV), Type (Small molecule, Biologics, Medical Devices) Therapeutic Areas (Oncology, CNS, CVD, Infectious, Immunology) - Global Forecast 2026", The global clinical trial supplies market is projected to reach USD 2.9 billion by 2026 from USD 1.9 billion in 2021, at a CAGR of 8.5% during the forecast period of 2021 to 2026.Browse and in-depth TOC on "Clinical Trial Supplies Market"237 – Tables47– Figures242 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059Growth Boosting Factors:Market growth is largely driven by the increasing R expenditure in pharmaceutical and biopharmaceutical companies and the growing number of clinical trials conducted globally.
However, the increasing cost of drug development and clinical trials is expected to restrain the growth of this market during the forecast period.The logistics and distribution segment accounted for the largest share of the services segment in the clinical trial supplies market in 2020.Based on the service, the clinical trial supplies market is segmented into manufacturing; packaging, labeling, and blinding; comparator sourcing; logistics & distribution; storage & retention; and other services.
Logistics & distribution and storage & retention are seen to be the leading segments with respect to the growth rate during the forecast period as a result of greater reliance on decentralization of clinical trials.The oncology segment accounted for the largest share of the therapeutic area segment in the clinical trial supplies market in 2020Based on the therapeutic area, the clinical trial supplies market is segmented into oncology, CNS & mental disorders, cardiovascular diseases, digestive disorders, infectious diseases, metabolic disorders, immunology, blood disorders, and other therapeutic areas (respiratory disorders, dermatological disorders, rare diseases, ENT diseases, Nephrology) Oncology is the largest segment in this market owing to the high and growing number of research studies on cancer therapeutics and the increasing number of companies focusing on bringing innovative cancer drugs into the market.
The huge population base, presence of less stringent and harmonized regulatory frameworks, and limited competition make patient recruitment and seeking approval for clinical trials more convenient, less time-consuming, and cost-efficient in the APAC region.
This is attracting the attention of a majority of pharmaceutical, biopharmaceutical, and biotechnology giants to consider conducting their clinical trials in APAC countries.
The Asia Pacific market is projected to register the highest growth during the forecast period due to the presence of many emerging players, less-stringent regulations, and the ease and cost-effectiveness of patient recruitment in APAC countries.Key Players:The global clinical trial supplies market is competitive.
The market for smoke evacuation systems is primarily driven by the rising patient preference for minimally invasive surgeries, increasing product availability, growing target patient population, and the availability of relevant OR protocols and guidelines for their use.The smoke evacuation pencils & wands segment accounted for the largest share of the smoke evacuation system market, by product type, in 2018On the basis of product type, the smoke evacuation system market is segmented into smoke evacuation pencils & wands, smoke evacuation filters, smoke evacuating systems, smoke-evac fusion products (shrouds), accessories, and smoke evacuation tubings.
The smoke evacuation pencils & wands segment accounted for the largest share of the smoke evacuation systems market in 2018.
The large share of the segment can be attributed to its growing adoption among healthcare facilities and its significant usage due to its advantage of creating safer and healthier environments for surgeons, nurses, technologists, and the surgical teams.Download the PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=149736406The laparoscopic surgeries application segment is expected to register the highest growth rate in the smoke evacuation systems market during the forecast period.On the basis of application, the smoke evacuation system market is segmented into medical aesthetic surgeries, open general surgeries, orthopedic surgeries, and laparoscopic surgeries.
The laparoscopic surgeries application segment is expected to register the highest growth rate due to the advantages of laparoscopic procedures over conventional open surgery and the need to improve the working environment in the operating room.North America dominated the global smoke evacuation systems market in 2018The large share of the North American market can mainly be attributed to the increasing number of surgical procedures, technological advancements, rising demand for minimally invasive surgeries, favorable reimbursement scenario, and rising government concerns regarding the health hazards of surgical plumes.CONMED Corporation (US), Medtronic Plc (Ireland), Olympus (Japan), Ethicon (US), Erbe Elektromedizin GmbH (Germany), KLS Martin (Germany), Stryker Corporation (US), I.C Medical (US), Symmetry Surgical Inc. (US), Utah Medical Products Inc (US), Zimmer Biomet (US), Pall Corporation (US), Ecolab (US), and Deroyal (US) are some major players in the global smoke evacuation systems market.Get the Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=149736406About MarketsandMarkets™MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues.
Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients.
Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM".
